The latest layoffs at Takeda, totaling 79 employees, reflect the company's ongoing restructuring efforts, signaling a need to enhance organizational agility and position for growth.
The company's strategy aims to maximize its late-stage pharmaceutical pipeline and enhance its growth portfolio, ensuring that Takeda remains competitive despite facing challenges.
Christopher Weber emphasized that the multi-year efficacy program is on track, focusing on procurement savings and advancing data and digital technology practices within the enterprise.
Despite the significant challenges posed by generic competition, including the loss of exclusivity for key products, Takeda is dedicated to navigating these hurdles through strategic initiatives.
Collection
[
|
...
]